Citichem India Limited, a major player in the chemical trading sector, has launched its Initial Public Offering (IPO), offering investors an opportunity to subscribe to 18 lakh fresh equity shares. The IPO, priced at ₹70 per share, is set to raise ₹12.60 Crores, aiming to fuel its expansion in the organic, inorganic, and food chemicals sectors. As of now, the IPO has garnered significant attention, with a subscription rate of 4.52x on its opening day, December 27, 2024. This detailed guide will walk you through everything you need to know about Citichem India IPO, from pricing to subscription status and allotment date.

Citichem India IPO Key Details

Citichem India IPO opens on December 27, 2024, and will close on December 31, 2024. With a share price set at ₹70 per equity share, the total market capitalization of the company at this price will be ₹47.60 Crores. Retail investors can apply for a minimum of ₹1,40,000 (2,000 shares), while High-Net-Worth Individuals (HNIs) must invest at least ₹2,80,000 (4,000 shares).

The lot size of the IPO is 2,000 shares, and the IPO is an entirely fresh issue of shares, offering no secondary sales. The subscription period for the IPO is expected to show strong demand, with Grey Market Premium (GMP) currently indicating a listing price of ₹90, a 28.57% premium over the issue price. This shows potential listing gains, though, as always, GMP is an unregulated measure and not indicative of final pricing.

Citichem India IPO Allotment and Listing
The allotment of Citichem India IPO shares is expected to be finalized on or about January 1, 2025, and the listing is anticipated on January 3, 2025. Investors can track the allotment status on the registrar's website, Kfin Technologies Limited, after the allotment date.

Citichem India IPO GMP and Subscription Status
The Grey Market Premium (GMP) of Citichem India IPO has fluctuated slightly but currently stands at ₹20, or 28.57% above the issue price. This reflects positive investor sentiment towards the company's financials and business model. The subscription status on December 27, 2024, shows a high demand, with the IPO already subscribed 4.52x on the first day.

Investors considering applying for the IPO should note that GMP and subscription status are useful for gauging market sentiment but should not solely influence investment decisions. The real price discovery will happen after the listing date, and the company’s financials should be a key consideration in any investment decision.

Financial Overview and Business Operations

Citichem India, led by Mr. Arif Esmail Merchant, has shown consistent growth over the years. The company sources and supplies a wide range of chemicals and bulk drugs across various industries, including pharmaceuticals, textiles, paints, dairy, and more. For the year ended June 30, 2024, the company reported ₹149.07 Lakhs in revenues, with a steady rise in profitability. With a pre-issue P/E ratio of 31.25x and a post-issue P/E ratio of 42.56x, the company is priced in line with the industry but slightly higher than some competitors.

Why Investors Should Be Cautious

Despite the GMP indicating potential gains, Citichem India’s P/E ratios suggest that the IPO is fully priced. The company's profit margins are healthy, but considering the higher P/E ratio, potential investors should weigh their risk tolerance and investment horizon. Given the competition in the chemical and pharmaceutical sectors, future growth prospects will play a crucial role in determining the success of this IPO post-listing.

Citichem India IPO Subscription Status
As per the latest reports, Citichem India IPO had a strong opening with 4.52 times subscription on the first day of its offering. The subscription details indicate robust demand across both retail investors and HNIs, though it is important to monitor subscription updates as the IPO period progresses.

Conclusion and Recommendation

While Citichem India IPO offers an attractive opportunity for those looking to invest in the chemical and pharmaceutical sectors, the P/E ratio and post-issue valuation may raise concerns for some. Given the GMP and financial performance, this IPO could provide short-term gains, but investors should exercise caution and consider long-term prospects before applying.

The Upcoming IPOs in this week and coming weeks are Indo Farm, Technichem Organics, Leo Dry Fruits, Solar91 Cleantech, Rosmerta Digital and Avanse Financial.

The Current active IPO is Citichem India and Anya Polytech.

For more details on upcoming IPOs, you can visit our page at  and stay updated with the latest news on IPO updates on . Join our  for regular Stock Market Trading and Investment Calls by  - SEBI Registered Research Analyst &  for Regular Share Market, News & IPO Updates. Start your Stock Market Journey and Apply in IPO by opening a Free Demat Account in .Best IPO to Apply Now - IPO List 2024, Latest IPO, Upcoming IPO, Recent IPO News, Live IPO GMP Today - Finance SaathiTop News Headlines - Share Market News, Latest IPO News, Business News, Economy News - Finance SaathiTrading with CA Abhay Telegram ChannelCA Abhay VarnFinance Saathi Telegram ChannelChoice Broking FinX.